Trump administration reclassifies marijuana to ease rules regarding cannabis research

The rescheduling follows an executive order President Donald Trump signed in December, which is aimed at expanding medical marijuana research.

Published: April 23, 2026 9:27am

The Trump administration on Thursday signed an order rescheduling marijuana from its current, highly restrictive level to a classification that eases regulations regarding cannabis research. 

The move doesn't legalize marijuana or remove criminal penalties for use and possession, but it reclassifies marijuana from its current Schedule I — which is the same classification as heroin and means it has a high potential for abuse and no accepted medical uses — to the lower classification of Schedule III. 

The move follows an executive order President Donald Trump signed in December, which is aimed at expanding medical marijuana research. 

"The Department of Justice is delivering on President Trump’s promise to expand Americans’ access to medical treatment options. This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information," Acting Attorney General Todd Blanche said in a statement

The Facts Inside Our Reporter's Notebook

Unlock unlimited access

  • No Ads Within Stories
  • No Autoplay Videos
  • VIP access to exclusive Just the News newsmaker events hosted by John Solomon and his team.
  • Support the investigative reporting and honest news presentation you've come to enjoy from Just the News.
  • Just the News Spotlight

    Support Just the News